This is just like that rival, it started as a diabetes treatment but became famous for weight loss
Preclinical and observational data suggest that side effects primarily depend on dosage, frequency, and individual metabolic response
Reporting the findings in JAMA Internal Medicine, the researchers including experts from Eli Lilly, the makers of Mounjaro, said participants who maintained the weight reduction to less than 25% regain at week 88 also maintained the benefits seen in central adiposity, triglycerides, non-HDL cholesterol, fasting insulin, and insulin resistance
Multidisciplinary collaboration is also important
For now, weekly, even monthly injectables, have a larger environmental footprint than 90 to 100 tablets in a vial, Lake noted